Impact of Race on Asthma Treatment Failures in the Asthma Clinical Research NetworkWECHSLER, Michael E; CASTRO, Mario; LEHMAN, Erik et al.American journal of respiratory and critical care medicine. 2011, Vol 184, Num 11, pp 1247-1253, issn 1073-449X, 7 p.Article

Engineering of Crystalline Combination Inhalation Particles of a Long-Acting β₂-agonist and a CorticosteroidPITCHAYAJITTIPONG, Chonladda; SHUR, Jagdeep; PRICE, Robert et al.Pharmaceutical research. 2009, Vol 26, Num 12, pp 2657-2666, issn 0724-8741, 10 p.Article

β₂-Receptor Polymorphisms in Patients Receiving Salmeterol with or without Fluticasone PropionateBLEECKER, Eugene R; NELSON, Harold S; KRAFT, Monica et al.American journal of respiratory and critical care medicine. 2010, Vol 181, Num 7, pp 676-687, issn 1073-449X, 12 p.Article

Therapeutic responses in asthma and COPD: BronchodilatorsDONOHUE, James F.Chest. 2004, Vol 126, Num 2, pp 125S-137S, issn 0012-3692, SUPArticle

Serious asthma exacerbations in asthmatics treated with high-dose formoterolMANN, Marianne; CHOWDLURY, Badrul; SULLIVAN, Eugene et al.Chest. 2003, Vol 124, Num 1, pp 70-74, issn 0012-3692, 5 p.Article

The relationship between combination inhaled corticosteroid and long-acting β-agonist use and severe asthma exacerbations in a diverse populationWELLS, Karen E; PETERSON, Edward L; AHMEDANI, Brian K et al.Journal of allergy and clinical immunology. 2012, Vol 129, Num 5, pp 1274-1279, issn 0091-6749, 6 p.Article

High-dose inhaled corticosteroids versus add-on long-acting β-agonists in asthma : An observational studyTHOMAS, Mike; VON ZIEGENWEIDT, Julie; LEE, Amanda J et al.Journal of allergy and clinical immunology. 2009, Vol 123, Num 1, pp 116-121, issn 0091-6749, 6 p.Article

Long-acting β-agonists : a review of formoterol safety data from asthma clinical trialsSEARS, M. R; OTTOSSON, A; RADNER, F et al.The European respiratory journal. 2009, Vol 33, Num 1, pp 21-32, issn 0903-1936, 12 p.Article

Advances in adult asthma diagnosis and treatment in 2012: Potential therapeutics and gene-environment interactionsAPTER, Andrea J.Journal of allergy and clinical immunology. 2013, Vol 131, Num 1, pp 47-54, issn 0091-6749, 8 p.Article

Effects of Salmeterol on Sleeping Oxygen Saturation in Chronic Obstructive Pulmonary DiseaseRYAN, Silke; DOHERTY, Liam S; ROCK, Clare et al.Respiration (Basel). 2010, Vol 79, Num 6, pp 475-481, issn 0025-7931, 7 p.Article

Is there a problem with inhaled long-acting β-adrenergic agonists?NELSON, Harold S.Journal of allergy and clinical immunology. 2006, Vol 117, Num 1, pp 3-16, issn 0091-6749, 14 p.Article

The Safety of Long-Acting p-Agonists among Patients with Asthma Using Inhaled Corticosteroids : Systematic Review and MetaanalysisJAESCHKE, Roman; O'BYRNE, Paul M; GUYATT, Gordon et al.American journal of respiratory and critical care medicine. 2008, Vol 178, Num 10, pp 1009-1016, issn 1073-449X, 8 p.Article

Considering therapeutic options in the real worldMARTIN, Richard J.Journal of allergy and clinical immunology. 2003, Vol 112, Num 5, pp S112-S115, issn 0091-6749, SUPConference Paper

Advances in adult asthma diagnosis and treatment and HEDQ in 2010APTER, Andrea J.Journal of allergy and clinical immunology. 2011, Vol 127, Num 1, pp 116-122, issn 0091-6749, 7 p.Article

Advances in adult asthma diagnosis and treatment and health outcomes, education, delivery, and quality in 2011: What goes around comes aroundAPTER, Andrea J.Journal of allergy and clinical immunology. 2012, Vol 129, Num 1, pp 69-75, issn 0091-6749, 7 p.Article

Single-dose montelukast or salmeterol as protection against exercise-induced bronchoconstrictionPHILIP, George; PEARLMAN, David S; VILLARDN, César et al.Chest. 2007, Vol 132, Num 3, pp 875-883, issn 0012-3692, 9 p.Article

Cardiac Safety Profile of Nebulized Formoterol in Adults with COPD : A 12-Week, Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-and Active-Controlled TrialNELSON, Harold S; GROSS, Nicholas J; LEVINE, Bernard et al.Clinical therapeutics. 2007, Vol 29, Num 10, pp 2167-2178, issn 0149-2918, 12 p.Article

Potential side effects in patients treated with inhaled corticosteroids and long-acting β2-agonistsKORSGAARD, J; LEDET, M.Respiratory medicine. 2009, Vol 103, Num 4, pp 566-573, issn 0954-6111, 8 p.Article

Effect of formoterol with or without budesonide in repeated low-dose allergen challengeDAHLEN, B; LANTZ, A.-S; IHRE, E et al.The European respiratory journal. 2009, Vol 33, Num 4, pp 747-753, issn 0903-1936, 7 p.Article

Novel long-acting bronchodilators for COPD and asthmaCAZZOLA, M; MATERA, M. G.British journal of pharmacology. 2008, Vol 155, Num 3, pp 291-299, issn 0007-1188, 9 p.Article

Inhaled Corticosteroids in Asthma ManagementSOBANDE, Patrick O; KERCSMAR, Carolyn M.Respiratory care. 2008, Vol 53, Num 5, pp 625-634, issn 0020-1324, 10 p.Conference Paper

Unscheduled healthcare resource use among asthma patients receiving low-dose inhaled corticosteroids maintenance treatmentBARNES, N. C; WILLIAMS, A. E.International journal of clinical practice (Esher). 2005, Vol 59, Num 9, pp 1017-1024, issn 1368-5031, 8 p.Article

Randomized controlled trial of adherence with single or combination inhaled corticosteroid/long-acting β-agonist inhaler therapy in asthmaPERRIN, Kyle; WILLIAMS, Mathew; WIJESINGHE, Meme et al.Journal of allergy and clinical immunology. 2010, Vol 126, Num 3, pp 505-510, issn 0091-6749, 6 p.Article

Acute asthma intervention : Insights from the STAY studyO'BYRNE, Paul M.Journal of allergy and clinical immunology. 2007, Vol 119, Num 6, pp 1332-1336, issn 0091-6749, 5 p.Article

Determinants of future long-term asthma controlSCHATZ, Michael; ZEIGER, Robert S; VOLLMER, William M et al.Journal of allergy and clinical immunology. 2006, Vol 118, Num 5, pp 1048-1053, issn 0091-6749, 6 p.Article